Studies of IL-1β in breast cancer have demonstrated that IL-1β expression is increased in 90% of oestrogen receptor-negative invasive breast carcinomas, and that it is localised to both tumour cells and stromal cells [9,36]. The gene discussed is IL1B; the disease is breast carcinoma.